Lingga, Hasna S.
HRN: 25-30-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
CEFTRIAXONE 1G (VIAL)
04/07/2025
04/14/2025
IV
2g
OD
CAP-HR (hypotension); PTB Presumptive
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes